Wednesday, October 16, 2019 3:20:23 PM
So how are they going to sell ARTGuide? Direct sales or through a partner or both?
Fertility RX is going to be sold for $0 to select clinics. That will last for at least 6 months.
The most recent PR with the Chinese bank is totally vague. Unless you are in the know, you don't have a clue what that is really all about.
The question is: How is PRED going to attract new investors. Most investors want it spelled out for them and don't want to try to read between the lines. Until something more obvious and impactful is announced, the stock price isn't going to move up much.
JMHO
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM